UPL Limited

UPL Limited is the world's leading post-patent generic agrochemical manufacturer, headquartered in Mumbai, India. Founded in 1969, UPL operates 43-44 global manufacturing sites and 24 R&D stations serving farmers in 140+ countries with over 13,000 employees. In FY2025, the company generated ₹466.4 billion ~US$5.65 billion in revenue. UPL's business model combines extreme manufacturing cost competitiveness with the innovative OpenAg collaboration platform.

• Crop Protection Chemicals: Comprehensive portfolio of post-patent herbicides, insecticides, fungicides, and miticides covering all major crops and pest spectrums • Specialty Chemicals & Intermediates: Active ingredient synthesis, chemical intermediates, and custom manufacturing for other agrochemical companies • Seeds via Advanta Enterprises: Field crop and vegetable seeds including sorghum, sunflower, corn, canola, and forage crops • Biologicals & Biostimulants: Natural Plant Protection NPP business unit providing microbial-based biopesticides and plant growth promoters • Soil & Water Technologies: Soil conditioners, water-retention polymers, and nutrient efficiency enhancers under the OpenAg platform • Post-Harvest Solutions: Fumigants, storage protectants, and shelf-life extension treatments for grains and produce

Market Position & Financial Strength

UPL Limited executed a textbook V-shaped recovery in FY2025, with revenue growing 8% to ₹466.4 billion and EBITDA surging 47% to ₹81.2 billion—driving margin expansion of 460 basis points to 17.4%. Net profit swung from a ₹12 billion loss in FY2024 to a ₹9 billion profit. The turnaround was propelled by a 56% North American revenue surge, aggressive working capital optimization (cash conversion cycle compressed from 86 to 53 days), and strategic portfolio actions that reduced net debt by ₹83.2 billion.

Technological Innovation & Moat

UPL's competitive moat is built on three pillars: unmatched manufacturing cost leadership through Indian/Asian production economics at scale, the industry's broadest post-patent active ingredient portfolio enabling one-stop-shop customer convenience, and the OpenAg ecosystem that accelerates innovation through collaborative R&D partnerships. The company is actively building biologicals and specialty product capabilities to diversify beyond commodity actives.

Sustainability & Future Outlook

UPL has achieved 60%+ Zero Liquid Discharge (ZLD) compliance at multiple manufacturing sites. The NPP biologicals portfolio positions UPL to participate in the structural shift toward reduced-chemical-input farming. Key risks include the inherent volatility of generic agrochemical pricing cycles and potential Western market trade protectionism targeting Indian chemical imports. VerityRank Score: 85/100